LINEAGE CELL THERAPEUTICS IN's ticker is and the CUSIP is 53566P959. A total of 2 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.9% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -77.8% | 2,000 | -66.7% | 0.00% | – |
| Q1 2022 | $9,000 | -65.4% | 6,000 | -45.0% | 0.00% | – |
| Q4 2021 | $26,000 | -67.1% | 10,900 | -60.8% | 0.00% | – |
| Q3 2021 | $79,000 | 0.0% | 27,800 | 0.0% | 0.00% | – |
| Q2 2021 | $79,000 | -54.1% | 27,800 | +3692.6% | 0.00% | – |
| Q1 2021 | $172,000 | +911.8% | 733 | +655.7% | 0.00% | – |
| Q4 2020 | $17,000 | +1600.0% | 97 | +361.9% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 21 | -36.4% | 0.00% | – |
| Q4 2019 | $2,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 21 | $1,000 | 0.00% |